XML 27 R17.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED AND OTHER COMPENSATION
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED AND OTHER COMPENSATION STOCK-BASED AND OTHER COMPENSATION
On March 27, 2018, the stockholders of Citizens Community Bancorp, Inc. approved the 2018 Equity Incentive Plan. The aggregate number of shares of common stock initially reserved and available for issuance under the 2018 Equity Incentive Plan was 350,000 shares. As of March 31, 2025, 331,968 restricted shares had been granted under this plan. This amount includes 16,021 shares of performance based restricted stock granted in 2022 and issued in January 2025 upon achievement of the performance criteria and completion of the three-year performance period beginning in January 2022 and ending December 31, 2024. The amount also includes 8,805 shares of performance based restricted stock granted in 2021 and issued in January 2024 upon achievement of the performance criteria and completion of the three year performance period beginning in January 2021 and ending December 31, 2023. As of March 31, 2025, no stock options had been granted under this plan.
In February 2008, the Company’s stockholders approved the Company’s 2008 Equity Incentive Plan for a term of 10 years. Due to the plan’s expiration, no new awards can be granted under this plan. As of March 31, 2025, there are no awarded unvested restricted shares, and 49,000 awarded unexercised vested options remaining from the plan. Options granted under this plan vested pro rata over a five-year period from the grant date and were fully vested as of October 2022. Unexercised incentive stock options expire within 10 years of the grant date.
Stock based compensation expense related to restricted stock awards from these plans was $68 for the three months ended March 31, 2025, compared to $158 for three months ended March 31, 2024.

Restricted Common Stock Award
March 31, 2025December 31, 2024
Number of SharesWeighted
Average
Grant Price		Number of SharesWeighted
Average
Grant Price
Restricted Shares
Unvested and outstanding at beginning of year39,171 $12.48 75,601 $12.41 
Granted— — 16,955 11.88 
Vested(31,562)12.43 (53,139)12.19 
Forfeited— — (246)11.88 
Unvested and outstanding at end of period7,609 $12.68 39,171 $12.48 

March 31, 2025
Number of SharesWeighted
Average
Grant Price
Performance Based Restricted Shares
Unvested at beginning of year33,188 $13.09 
2022 performance shares awarded above target1,154 14.00 
Vested and issued 2022 performance shares(16,021)14.00 
Unvested at end of period18,321 $12.36 

December 31, 2024
Number of SharesWeighted
Average
Grant Price
Performance Based Restricted Shares
Unvested at beginning of year41,993 $12.61 
Granted— — 
Vested and issued(8,805)10.78 
Forfeited— — 
Unvested at end of period33,188 $13.09 
Common Stock Option Awards
Option SharesWeighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Term in Years		Aggregate
Intrinsic
Value
March 31, 2025
Outstanding at beginning of year52,000 $11.62 
Exercised(3,000)9.20 
Outstanding at end of period49,000 $11.77 1.71$128 
Exercisable at end of period49,000 $11.77 1.71$128 
December 31, 2024
Outstanding at beginning of year54,000 $11.59 
Exercised(2,000)11.00 
Outstanding at end of year52,000 $11.62 1.85$243 
Exercisable at end of year52,000 $11.62 1.85$243 
Information related to the 2008 Equity Incentive Plan for the respective periods follows:
Three months ended March 31, 2025Twelve months ended December 31, 2024
Intrinsic value of options exercised$19 $12 
Cash received from options exercised$28 $22 
Tax benefit realized from options exercised$— $— 
Other Compensation
On January 23, 2025, the Company’s board of directors approved a phantom stock plan as part of the Company’s long-term incentive plan. The Plan allows certain employees to earn future cash awards linked to the company’s future common share price for time and performance based cash awards. The performance based cash awards vest based on a combination of a three-year time period from January 23, 2025 through December 31, 2027, and performance targets based on the Company’s return on equity. For performance based awards, the ultimate cash payout of these awards will be paid within 60 days of December 31, 2027, based on the closing share price of the Company’s common stock as of the performance achievement approval date from the Compensation Committee. The time based cash awards vest ratably over a three-year time period. For time based awards, the ultimate cash payout of these awards will be based on the closing share price of the Company’s common stock on the anniversary of the award date each year. On January 23, 2025, time based awards were based on 15,044 shares and performance based awards were based on 15,049 shares.
On January 25, 2024, the Company’s board of directors approved a phantom stock plan as part of the Company’s long-term incentive plan. The Plan allows certain employees to earn future cash awards linked to the company’s future common share price for time and performance based cash awards. The performance based cash awards vest based on a combination of a three-year time period from January 25, 2024 through December 31, 2026, and performance targets based on the Company’s return on equity. For performance based awards, the ultimate cash payout of these awards will be paid within 60 days of December 31, 2026, based on the closing share price of the Company’s common stock as of the performance achievement approval date from the Compensation Committee. The time based cash awards vest ratably over a three-year time period. For time based awards, the ultimate cash payout of these awards will be based on the closing share price of the Company’s common stock on the anniversary of the award date each year. On January 25, 2024, time based awards were based on 18,509 shares and performance based awards were based on 18,505 shares.
At the end of each reporting period, the Company estimates its potential liability related to the Plan and records any change to this liability as compensation expense in the consolidated statement of operations. At March 31, 2025 and December 31, 2024, the related liability was $150 and $190, respectively, which is included in other liabilities on the consolidated balance sheet. For the three months ended March 31, 2025 and March 31, 2024, the Company recorded related expense of $59 and $26, respectively, which is included in compensation and related benefits/non-interest expense on the Company’s consolidated statement of operations.